LOS ANGELES, March 21, 2024 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections,…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
